Protein therapeutics market to grow by $172.8b until 2028

It is anticipated to grow at a 9.47% CAGR within the forecast period.

The global market for protein therapeutics is projected to grow by $172.8b until 2028 at a compound annual growth rate (CAGR) of 9.47%.

A report by Technavio revealed that the market is driven by a rising prevalence of chronic diseases, advancements in protein production, and an increasing demand for targeted therapies.

“The market for protein therapy is significant in major healthcare institutions, where treatments like chemotherapy and monoclonal antibodies segment are commonly administered for immunological diseases and haematological disorders,” The report said.

Meanwhile, regulatory approvals and partnerships between academic institutions and biotech companies further fuel the market’s expansion.

According to Technavio, the market holds significant potential in developing economies amidst the continuous rise of the demand for quality drugs and advanced treatments.